Heart Disease Trial, Recruiting NCT06180603 Sponsor: University of Aarhus Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06180603
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who are admitted to an emergency department
  • People who have a build-up of fluid around the lungs, detected by an ultrasound, chest X-ray, or CT scan
  • People for whom a doctor has determined that draining the fluid is medically necessary — either to relieve symptoms or to find out why the fluid is there
  • People who do not have any medical reasons that would make draining the fluid unsafe in an emergency department setting (for example, being on blood-thinning medication)

Who may not be able to join:

  • People experiencing severe, life-threatening difficulty breathing
  • People who are unable to give their consent to participate
  • People who have previously had a procedure to permanently seal the space around their lungs (pleurodesis)
  • People whose fluid around the lungs does not appear to move freely, is divided into pockets, or where a serious infection of that fluid (empyema) is suspected
  • People who have already taken part in this trial before
  • People where the decision to drain the fluid has already been made by the radiology department, making random assignment to a treatment group not possible

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sandra T Langsted, Aarhus University Hospital

Phone: +45 20 27 65 12

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 January 2024
Est. completion
30 November 2025

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Time from identification of the clinical indication for thoracentesis to complete drainage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov